Parkman Healthcare Partners’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100,955
| Closed | -$2.07M | – | 96 |
|
|
2025
Q1 | $2.07M | Buy |
100,955
+24,839
| +33% | +$508K | 0.25% | 75 |
|
|
2024
Q4 | $1.96M | Sell |
76,116
-29,218
| -28% | -$751K | 0.26% | 73 |
|
|
2024
Q3 | $1.75M | Sell |
105,334
-30,042
| -22% | -$499K | 0.22% | 79 |
|
|
2024
Q2 | $2.6M | Sell |
135,376
-64,935
| -32% | -$1.25M | 0.35% | 68 |
|
|
2024
Q1 | $4.74M | Sell |
200,311
-100,439
| -33% | -$2.38M | 0.58% | 57 |
|
|
2023
Q4 | $3.36M | Buy |
300,750
+51,726
| +21% | +$578K | 0.47% | 64 |
|
|
2023
Q3 | $2.3M | Buy |
249,024
+9,973
| +4% | +$92.3K | 0.42% | 67 |
|
|
2023
Q2 | $2.84M | Buy |
239,051
+124,051
| +108% | +$1.47M | 0.49% | 61 |
|
|
2023
Q1 | $1.52M | Buy |
+115,000
| New | +$1.52M | 0.33% | 66 |
|